# KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections

> **NCT00132951** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 2051 (actual)

## Conditions studied

- Respiratory Tract Infections
- Chronic Bronchitis
- Pneumonia

## Interventions

- **DRUG:** Telithromycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00132951
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 2051 (ACTUAL)
- **Last updated:** 2009-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132951, "KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00132951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*